Alerts will be sent to your verified email
Verify EmailNECLIFE
|
Nectar Lifesciences
|
Everest Organics
|
Tyche Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Filed in USA
|
15.0 . | n/a | n/a |
|
Global DMFs filed
|
104.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.97 % | 1.16 % | 1.28 % |
|
Financials
|
|||
|
5 yr Average ROE
|
0.55 % | 6.44 % | 12.13 % |
|
5yr average Equity Multiplier
|
2.12 | 3.85 | 1.16 |
|
5yr Average Asset Turnover Ratio
|
0.73 | 0.99 | 0.53 |
|
5yr Avg Net Profit Margin
|
-2.27 % | 1.46 % | 19.18 % |
|
Price to Book
|
0.35 | 3.38 | 0.98 |
|
P/E
|
0.0 | 42.05 | 20.51 |
|
5yr Avg Cash Conversion Cycle
|
88.68 Days | -104.59 Days | 111.78 Days |
|
Inventory Days
|
136.85 Days | 70.24 Days | 69.03 Days |
|
Days Receivable
|
69.3 Days | 188.66 Days | 101.01 Days |
|
Days Payable
|
116.07 Days | 263.18 Days | 90.14 Days |
|
5yr Average Interest Coverage Ratio
|
0.46 | 2.08 | 2385.83 |
|
5yr Avg ROCE
|
3.29 % | 11.9 % | 16.3 % |
|
5yr Avg Operating Profit Margin
|
5.36 % | 5.27 % | 21.21 % |
|
5 yr average Debt to Equity
|
0.71 | 0.88 | 0.0 |
|
5yr CAGR Net Profit
|
9.19 % | n/a | -9.09 % |
|
5yr Average Return on Assets
|
-1.73 % | 2.03 % | 10.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.84 % | 59.58 % | 61.97 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.96 % | -14.57 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Nectar Lifesciences
|
Everest Organics
|
Tyche Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|